Assessment of Artemisinin-Based Combination Therapy (ACT) Prescription Patterns and Practices in Private Healthcare Facilities in Lagos State, Nigeria
DOI:
https://doi.org/10.5281/Keywords:
Prescription pattern, Artemisinin-Based Combination Therapy, Antimalarial, Practice, MalariaAbstract
Malaria remains a significant public health challenge across 97 countries and territories in tropical and subtropical regions. Prompt and accurate diagnosis is essential for effective malaria management. This study aimed to evaluate the prescription patterns of Artemisinin-Based Combination Therapies (ACTs) and related practices in private health facilities in Lagos State, Nigeria. A cross-sectional descriptive study design was employed, utilizing a questionnaire checklist to gather data from 21 practicing physicians and 2,720 patients. Data analysis was conducted using the Statistical Product for Social Sciences (SPSS) version 26, with results presented through descriptive statistics. Artemether-Lumefantrine was the most frequently prescribed ACT, accounting for 47.33% of prescriptions (1,305 patients). Commonly prescribed brands included Coartem, Lonart, and Amatem Forte, with formulations adapted as tablets, dispersible tablets, or suspensions where appropriate. Additionally, ciprofloxacin (23.31%) and azithromycin (17.48%) were frequently prescribed, reflecting a tendency toward combining ACTs with antibiotics and analgesics for malaria treatment and management. The findings indicate a prevailing practice of integrating ACTs with other medications, often without strict adherence to confirmatory diagnostic protocols. To optimize malaria treatment outcomes, it is recommended that healthcare practitioners adhere to best practices by utilizing ACTs solely after confirmatory laboratory tests to ensure accurate diagnosis and treatment.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 J. M. Ibu, J. J. Etim, O. S. Efegene, E. I. Ekpo, C. C. Otali, O. J. Etim-John, N. N. Agbiji, I. E. Idem (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Permissible Uses and Attribution
- Citation: Any use or reproduction of content from EMSAJ Publishing Global journals must include the customary bibliographic citation, including author attribution, date, and article title.
- Permission: For commercial use or reproduction beyond fair use guidelines, explicit permission must be obtained from EMSAJ Publishing Global or the copyright holder.